Aditya Birla Sun Life Pharma and Healthcare Fund-Direct - Payout of IDCW

Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)Very High RiskISIN INF209KB1O33

NAV · 06-Jul-2026

₹25.6200

+7.53%

+8.03%

1Y (CAGR)

+9.23%

3Y (CAGR)

+16.25%

5Y (CAGR)

+7.09%

Since inception (CAGR)

+14.32%

NAV history

hover for values

Risk & SIP analytics

Q2 · 3Y in category

Volatility (3y)

14.77%

Downside dev (3y)

13.23%

Max drawdown (3y)

-20.9%

Sharpe (3y)

0.66

SIP XIRR (3y)

+11.04%

SIP XIRR (5y)

+12.62%

Calendar-year returns

2020 +43.5%2021 +12.8%2022 -16.6%2023 +29.6%2024 +28.0%2025 -3.1%

Fund facts

Fund managerDhaval Shah

AUM₹9,503 Cr

Expense ratio0.84% · 2026-05-31

Launch date20-Jun-2019

Plan typeOpen Ended · Equity

Min lumpsum₹1,000

Min SIP₹100

Lock-inNone

Volatility16.55

AMCAditya Birla Sun Life AMC Limited

Objective · The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

scheme documents ↗